AbbVie

The BioPharma company was founded in 2013 as a spin-off AbbVie of Abbott Laboratories and is traded on the New York Stock Exchange ( NYSE) under the symbol " ABBV ". Activity is AbbVie among others in the fields of immunology, oncology and virology. The worldwide turnover amounted to USD 18.79 billion in 2013.

Therapy / Research

AbbVie working and researching in the therapeutic areas of hepatitis C, rheumatoid arthritis, psoriasis, multiple sclerosis, Alzheimer's, Parkinson's disease, multiple myeloma and endometriosis. Largest product of AbbVie is the " blockbuster" Adalimumab (brand name Humira ).

AbbVie Germany

The AbbVie Germany GmbH & Co. KG is based in Wiesbaden. Managing directors are Alexander cube, Friedrich Richter and William J. Chase.